关于我们
Cerium Pharmaceuticals is dedicated to creating efficacious therapies for patients with kidney diseases. Cerium is currently focused on developing the first drug approved for a very rare kidney disease called Primary Membranous Nephropathy (PMN). There are approximately 75,000 PMN patients in the US and approximately 3,000 newly diagnosed PMN patients per year.
- 网站
-
https://www.ceriumpharma.com
Cerium Pharmaceuticals的外部链接
- 所属行业
- 制药业
- 规模
- 2-10 人
- 类型
- 私人持股
- 创立
- 2012
- 领域
- Rare Diseases、Orphan Drugs和Nephrology